Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Baumert, Jens; Huang, Jie; McKnight, Barbara; Sabater-Lleal, Maria; Steri, Maristella; Chu, Audrey Y.; Trompet, Stella; Lopez, Lorna M.; Fornage, Myriam; Teumer, Alexander; Tang, Weihong; Rudnicka, Alicja R.; Mälarstig, Anders; Hottenga, Jouke-Jan; Kavousi, Maryam; Lahti, Jari; Tanaka, Toshiko; Hayward, Caroline; Huffman, Jennifer E.; Morange, Pierre-Emmanuel; Rose, Lynda M.; Basu, Saonli; Rumley, Ann; Stott, David J.; Buckley, Brendan M.; Craen, Anton J. M. de; Sanna, Serena; Masala, Marco; Biffar, Reiner; Homuth, Georg ... view all 103 authors View less authors (2014)
Publisher: Ludwig-Maximilians-Universität München
Languages: English
Types: Article
Subjects: INFLAMMATORY MARKERS, CARDIOVASCULAR-DISEASE RISK, Research Article, Myocardial infarction, ASSOCIATION, 515 Psychology, CIGARETTE-SMOKING, INDIVIDUAL PARTICIPANT METAANALYSIS, Lung cancer, Cigarette smoking, Epidemiology, LUNG-CANCER, CIRCULATING FIBRINOGEN, LOCI, Cardiovascular disease risk, Genetic variation, Medicine, Cardiology, 3121 Internal medicine, Q, MYOCARDIAL-INFARCTION, Medizin, R, Hematology, Science, Clinical Genetics, Medicine and Health Sciences, GENETIC-VARIATION
ddc: ddc:610
textabstractPlasma fibrinogen is an acute phase protein playing an important role in the blood coagulation cascade having strong associations with smoking, alcohol consumption and body mass index (BMI). Genome-wide association studies (GWAS) have identified a variety of gene regions associated with elevated plasma fibrinogen concentrations. However, little is yet known about how associations between environmental factors and fibrinogen might be modified by genetic variation. Therefore, we conducted large-scale meta-analyses of genome-wide interaction studies to identify possible interactions of genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentration. The present study included 80,607 subjects of European ancestry from 22 studies. Genome-wide interaction analyses were performed separately in each study for about 2.6 million single nucleotide polymorphisms (SNPs) across the 22 autosomal chromosomes. For each SNP and risk factor, we performed a linear regression under an additive genetic model including an interaction term between SNP and risk factor. Interaction estimates were meta-analysed using a fixed-effects model. No genome-wide significant interaction with smoking status, alcohol consumption or BMI was observed in the meta-analyses. The most suggestive interaction was found for smoking and rs10519203, located in the LOC123688 region on chromosome 15, with a p value of 6.2×10-8. This large genome-wide interaction study including 80,607 participants found no strong evidence of interaction between genetic variants and smoking status, alcohol consumption or BMI on fibrinogen concentrations. Further studies are needed to yield deeper insight in the interplay between environmental factors and gene variants on the regulation of fibrinogen concentrations.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Krobot K, Hense HW, Cremer P, Eberle E, Keil U (1992) Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12: 780-788.
    • 2. Folsom AR (1995) Epidemiology of fibrinogen. Eur Heart J 16 Suppl A: 21-23.
    • 3. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, et al. (1996) Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators. Am J Epidemiol 143: 665-676.
    • 4. Burger M, Mensink G, Bronstrup A, Thierfelder W, Pietrzik K (2004) Alcohol consumption and its relation to cardiovascular risk factors in Germany. Eur J Clin Nutr 58: 605-614.
    • 5. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, et al. (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26: 1765-1773.
    • 6. Sinha S, Luben RN, Welch A, Bingham S, Wareham NJ, et al. (2005) Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPICNorfolk) population. Eur J Cardiovasc Prev Rehabil 12: 144-150.
    • 7. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, et al. (2007) Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 166: 867-879.
    • 8. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, et al. (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant metaanalysis. JAMA 294: 1799-1809.
    • 9. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367: 1310-1320.
    • 10. Koenig W (2003) Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89: 601-609.
    • 11. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ (2001) The genetics of haemostasis: a twin study. Lancet 357: 101-105.
    • 12. Yang Q, Tofler GH, Cupples LA, Larson MG, Feng D, et al. (2003) A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study. Thromb Res 110: 57-64.
    • 13. Kathiresan S, Yang Q, Larson MG, Camargo AL, Tofler GH, et al. (2006) Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 26: 1405-1412.
    • 14. Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, et al. (2008) Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol 52: 941-952.
    • 15. Danik JS, Pare G, Chasman DI, Zee RY, Kwiatkowski DJ, et al. (2009) Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Circ Cardiovasc Genet 2: 134-141.
    • 16. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, et al. (2009) Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2: 125-133.
    • 17. Sabater-Lleal M, Huang J, Chasman D, Naitza S, Dehghan A, et al. (2013) Multiethnic meta-analysis of genome-wide association studies in .100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 128: 1310-1324.
    • 18. Hamsten A, Iselius L, de Faire U, Blomback M (1987) Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 2: 988-991.
    • 19. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, et al. (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101: 1546-1551.
    • 20. de Maat MP (2001) Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann N Y Acad Sci 936: 509-521.
    • 21. Green F, Hamsten A, Blomback M, Humphries S (1993) The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 70: 915-920.
    • 22. Thomas AE, Green FR, Humphries SE (1996) Association of genetic variation at the beta-fibrinogen gene locus and plasma fibrinogen levels; interaction between allele frequency of the G/A-455 polymorphism, age and smoking. Clin Genet 50: 184-190.
    • 23. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, et al. (2009) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective metaanalyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2: 73-80.
    • 24. CLAUSS A (1957) [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 17: 237-246.
    • 25. Cremer P, Nagel D, Labrot B, Mann H, Muche R, et al. (1994) Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 24: 444-453.
    • 26. Marchini J, Howie B, Myers S, McVean G, Donnelly P (2007) A new multipoint method for genomewide association studies by imputation of genotypes. Nat Genet 39: 906-913.
    • 27. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834.
    • 28. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55: 997-1004.
    • 29. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-2191.
    • 30. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
    • 31. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
    • 32. Liu P, Vikis HG, Wang D, Lu Y, Wang Y, et al. (2008) Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 100: 1326-1330.
    • 33. Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, et al. (2010) Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 102: 959-971.
  • No similar publications.